Table 2.
Independent Poor Prognostic Factors of Overall Survival
| Patient Characteristics | Hazard Ratio | p-value | Prog Score |
|---|---|---|---|
| Skin Metastasis | 4.49 | <0.0001 | 130 |
| Low BMI < 18.5 | 2.09 | 0.0003 | 81 |
| High Serum LDH (> ULN) | 1.74 | <0.0001 | 48 |
| Adrenal Metastasis | 1.52 | 0.0002 | 52 |
| PS 1 (vs. PS 0) | 1.45 | <0.0001 | 35 |
| Low Serum Albumin (< LLN) | 1.45 | <0.0001 | 32 |
| Gender - Male | 1.39 | 0.0002 | 37 |
| Bone Metastasis | 1.39 | 0.0002 | 29 |
| Histology - LCC/NOS (vs. AC/ACLP) | 1.29 | 0.006 | 30 |
| Mediastinal Nodes | 1.23 | 0.02 | 42 |
| No Bevacizumab (PC Alone) | 1.18 | 0.05 | 25 |